HIV-1 C4-V3 Polyvalent Peptide Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HIV-1 C4-V3 Polyvalent Peptide Vaccine, covering 2013-05-06 to 2013-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons [Phase 1]